Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity Pharmacotherapy
Phenomix Sciences · Obesity & Overweight
Not applicable
Not yet recruiting
424
2026-07
Industry sponsor intelligence
Phenomix SciencesClinical Pipeline.
Lead-sponsor view of Phenomix Sciences's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 1
- Recruiting
- 0
- Active
- 1
- Completed
- 0
- Results posted
- 0
- Avg enrollment
- 424
Pipeline overview
Programs by phase and activity.
Velocity
Phenomix Sciences trials by start year
Study start year · indexed snapshot
Development
Trials by phase
1phase labels
Early Phase 10
Phase 10
Phase 20
Phase 30
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Semaglutide → | 1 | 0 | 0 | 0 | 0 | 1 |
| Tirzepatide → | 1 | 0 | 0 | 0 | 0 | 1 |
Active peptide trials
In motion now.
NCT IDStudyPhase / statusEnrollmentUpdated
Completed trials
Finished registry records.
No studies in this snapshot.
Search sponsor records
All Phenomix Sciences studies.
This page groups studies where Phenomix Sciences is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
1 matching study
Last registry update first
Recent updates